EACS 2019

6–9 November 2019 // Basel, Switzerland

Over the 6-9 November, the 17th European AIDS Conference was held in Basel, Switzerland.

The European AIDS Conference is a biennial conference which aims to bring together scientists from across Europe to share the latest clinical research and developments in the field of HIV, and is in instrumental in shaping the future of HIV science and medicine.

Gilead Sciences was a platinum sponsor for this year’s event, providing support for two symposiums:

Together We Can

Wednesday 6th Nov; 15:00- 16:30
San Francisco Room, Basel Congress Center

With the global community focusing on prevention, viral suppression and lifelong good health of people living with HIV (PLHIV), the drive towards the ultimate elimination of HIV is a greater reality.

This symposium profiled Gilead’s efforts towards the ‘90-90-90’ targets set by UNAIDS in 2014 and addressing the specific needs of key communities.

Key thought leaders shared examples of best practice, evolving models of care, and discussed the importance of taking an inclusive approach to stopping the virus and ensuring that no one is left behind.

Hearing Individual Voices

Friday 8th Nov; 12:15- 13:45
San Francisco Room, Basel Congress Center

During this symposium, we investigated a variety of patient-related issues and concerns using immersive case studies, to we explore how patients think and feel at different stages in their HIV journey and how treatment can be tailored to achieve the best possible health outcomes.

These interactions unveil how patient preferences and physician perspectives can interact and align to effectively manage HIV.

Now reading: EACS 2019